UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000004393 |
|---|---|
| Receipt number | R000005250 |
| Scientific Title | Searching neural correlates of changes in social impairments induced by intranasal oxytocin administration and its association with genotypes related to oxytocin in subjects with autism spectrum disorder |
| Date of disclosure of the study information | 2010/10/15 |
| Last modified on | 2011/10/13 19:07:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Searching neural correlates of changes in social impairments induced by intranasal oxytocin administration and its association with genotypes related to oxytocin in subjects with autism spectrum disorder
Acronym
Searching changes in brain activation induced by intranasal oxytocin and its association with genotypes related to oxytocin in subjects with autism spectrum disorder
Scientific Title
Searching neural correlates of changes in social impairments induced by intranasal oxytocin administration and its association with genotypes related to oxytocin in subjects with autism spectrum disorder
Scientific Title:Acronym
Searching changes in brain activation induced by intranasal oxytocin and its association with genotypes related to oxytocin in subjects with autism spectrum disorder
Region
| Japan |
Condition
Condition
Autism spectrum disorder
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
1) Examining functional Magnetic Resonance Imaging signal changes induced by intranasal oxytocin administration in subjects with autism spectrum disorder
2) Examining association between functional Magnetic Resonance Imaging signal changes induced by intranasal oxytocin and genotypes related to oxytocin in subjects with autism spectrum disorder
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Bold signal changes of functional Magnetic Resonance Imaging
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Single intranasal administration of 24 units oxytocin (Syntocinon spray)
Interventions/Control_2
Single intranasal administration of placebo
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 55 | years-old | > |
Gender
Male
Key inclusion criteria
1) Subjects diagnosed with high-functioning autism, Asperger disorder, or pervasive developmental disorder not otherwise specified using Autism Diagnostic Interview-Revised
2) Subjects with normal intelligent (Verbal IQ > 90 and total IQ > 80 measured with Wechsler Adult Intelligent Scale Revised)
Key exclusion criteria
1) History of allergy for oxytocin
2) Cannot enter Magnetic Resonance Scanner
3) History of traumatic brain injury with any known cognitive consequences or loss of consciousness for more than 5 minutes
4) History of substance abuse or addiction
5) Instabilized with psychiatric comorbidity
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hidenori Yamasue |
Organization
Graduate School of Medicine, University of Tokyo
Division name
Department of Neuropsychiatry
Zip code
Address
7-3-1 Hongo, Bunkyo-ku, Tokyo
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
The University of Tokyo Hospital
Division name
Clinical Research Center
Zip code
Address
TEL
3-5800-8743
Homepage URL
Sponsor or person
Institute
Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo
Institute
Department
Personal name
Funding Source
Organization
Japan Science and Technology Agency
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2010 | Year | 10 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 10 | Month | 05 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 10 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2010 | Year | 10 | Month | 15 | Day |
Last modified on
| 2011 | Year | 10 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005250
